ADC Therapeutics S.A.
ADCTNYSEHealthcare● Active
$1.02
+$0.04(+3.82%)
Market Cap$129098865
P/E Ratio—
52W High$4.98
52W Low$0.7796
ADC Therapeutics S.A.（ADCT）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ADCT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($142.62M) | ($157.85M) | ($240.05M) | ($157.13M) | ($230.03M) |
| Depreciation & Amort. | $1.88M | $3.28M | $3.27M | $5.74M | $2.63M |
| Stock-Based Comp. | $6.91M | $6.57M | $13.49M | $50.64M | $60.48M |
| Change in Working Capital | ($25.36M) | $3.83M | $44.27M | ($49.03M) | ($15.71M) |
| Net Cash from Operations | ($141.17M) | ($123.83M) | ($118.69M) | ($138.31M) | ($233.38M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.26M) | ($0.87M) | ($3.22M) | ($0.69M) | ($6.38M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.40M | ($0.87M) | ($3.22M) | ($0.69M) | ($6.67M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | ($1.31M) | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | ($2.71M) | $48.61M |
| Net Cash from Financing | $150.94M | $97.05M | $73.88M | ($0.90M) | $267.39M |
| Free Cash Flow | |||||
| Free Cash Flow | ($141.44M) | ($124.70M) | ($121.90M) | ($139.00M) | ($239.75M) |
| FCF Margin %(computed) | -173.85% | -176.04% | -175.25% | -66.22% | -706.88% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解ADC Therapeutics S.A.
关于ADC Therapeutics S.A.（ADCT）现金流量表
ADC Therapeutics S.A. 2025财年经营活动现金流($0.14B)，自由现金流($0.14B)（FCF利润率-173.85%），资本支出($0.00B)。
常见问题
ADCT · 4 问ADC Therapeutics S.A. 2025财年自由现金流($0.14B)，同比down13.4%。
ADCT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10